NEW YORK--(BUSINESS WIRE)--Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ solutions as prescription medical treatments, today announced that Ross Muken, Chief Financial Officer, will give a corporate presentation and will participate in a digital therapeutics panel discussion at the Cowen and Company 40th Annual Healthcare Conference. The presentation will be at 8:30 a.m. ET and the panel will take place at 1:30 p.m. ET on Tuesday, March 3 at the Boston Marriott Copley Place.
Investors attending the conference who would like to schedule one-on-one meetings with Click executives can do so by contacting Ross Muken.
About Click Therapeutics
Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults. For more information, visit www.ClickTherapeutics.com.